House Lawmakers Introduced BEDROCK Act for Biomanufacturing
The proposed legislation targets supply chain security by mandating a federal action plan to boost domestic manufacturing.
Updated on Sept. 22, 2026 in Manufacturing
Live Poll
Should the federal government intervene to shift manufacturing operations back to the United States?
On August 27, 2026, Representatives Bob Latta and Debbie Dingell introduced the BEDROCK Act in the House of Representatives to bolster domestic biomanufacturing. The legislation aims to transition American research into industrial production to reduce reliance on foreign capacity.
Why it matters
The act seeks to address a competitive gap where China currently dominates global fermentation capacity. By prioritizing a domestic action plan, the legislation intends to secure supply chains for materials and medicines produced through biological processes.
The proposed legislation attempts to shift biomanufacturing production from current global reliance, dominated by China, toward domestic industrial capacity. The number of U.S. manufacturing jobs potentially affected by this transition remains dependent on the finalized action plan.
The players
Bob Latta
A U.S. Representative who co-introduced legislation focused on securing domestic manufacturing supply chains.
Debbie Dingell
A U.S. Representative who co-sponsored the bill to prioritize the expansion of American industrial biomanufacturing.
The details
The BEDROCK Act mandates that the Secretary of Commerce draft a prioritized action plan to formalize how the U.S. scales biological processes for industrial use. By requiring this federal strategy, the bill aims to bridge the gap between early-stage American scientific inventions and their transition to domestic mass production. Operators in the biotech and chemical manufacturing sectors should watch how this strategy impacts the availability and cost of domestic raw materials.
Timeline
August 27, 2026: Representatives introduced the BEDROCK Act.
Market Landscape
The BEDROCK Act follows the pattern established by the CHIPS and Science Act of 2022 to address industrial dependencies on foreign powers. It represents a broader legislative trend of utilizing federal action plans to de-risk critical manufacturing supply chains.
Manufacturers should monitor the legislative progress of the BEDROCK Act as it could eventually alter federal investment priorities for fermentation and biological production facilities. Businesses in this sector should evaluate their reliance on current fermentation supply chains against potential future shifts toward domestic requirements.
The takeaway
The proposed legislation signals a government-led push to industrialize domestic biological production methods. Operators should track the bill's advancement to understand how potential future mandates for domestic sourcing may affect their production costs and vendor relationships.
Further reading
For broader trends in industrial policy, see more in Manufacturing.
Live Poll
Should the federal government intervene to shift manufacturing operations back to the United States?
